Gemcitabine-induced progressive and sustained tumour response in a patient with multi-drug resistant uterine leiomyosarcoma

BACKGROUND: despite the fact that the combination of gemcitabine (GCB) and docetaxel shows an increased benefit for disease-free survival and overall survival compared to GCB alone in patients with soft-tissue sarcoma, GCB mono-chemotherapy should be considered as a preferable option with respect to...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: De Pas, T, Spitaleri, G, Vigna, PD, Toffalorio, F, Curigliano, G, Gambino, A, Boselli, S, Catania, C, de Braud, F
Médium: Artigo
Jazyk:Inglês
Vydáno: Cancer Intelligence 2008
Témata:
Case Reports
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC3234072/
https://ncbi.nlm.nih.gov/pubmed/22275981
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3332/ecancer.2008.102
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky